Komori
Seed (7743) · TargetReframedLatest Occurring Fact (2026-10-14): "Advanced"

Prime Market Selection and Early Achievement of Listing Maintenance Criteria

First written in FY2022-Q2. 3 of 10 entries say "Advanced", first in FY2022-Q3. Latest entry: 2026-10-14.

10entries
6years
6from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseAdvancedFY2022-Q3 – FY20222021: 12022: 220222023: 020232024: 020242025: 020252026: 72026
Same theme, other companies
Change to the Standard Market after transitioning to the Tokyo Stock Exchange Prime MarketA theme 80 companies write about · 6 as a headwind · 5 as a tailwind

The whole theme swung hardest in 2022: 10 of 45 companies on the "Worse" side.

2 other companies' latest entry also says "Advanced".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 80 companies compared. The sentences above are computed from all 80.
Full recordFilings, disclosures and news, newest first
  1. FY2026ReframedAnnual report

    「As of 31 March 2026, the Company changed its Tokyo Stock Exchange market segment from the Prime Market to the Standard Market because its listed shares market capitalisation did not meet the continued listing criteria. Following the change in market segment, it will continue to seek sustainable, medium- to long-term increases in corporate value through measures including stronger corporate governance and management that takes capital costs and share prices into account.」

    Because it failed to meet the continued listing criterion for listed shares market capitalisation, the Company changed from the Prime Market to the Standard Market and restructured its policy from the former goal of remaining on the Prime Market around increasing corporate value and strengthening governance.
  2. FY2022AdvancedAnnual report

    「In the Tokyo Stock Exchange's market reorganisation implemented on 4 April 2022, the Company moved to the Prime Market. At present, it continues to fail to meet only the “listed shares market capitalisation” criterion among the Prime Market's continued listing criteria.」

    Although the Company moved to the Prime Market, it continues not to meet the continued listing criterion for listed shares market capitalisation and is continuing efforts to achieve it at an early date.
  3. FY2022-Q3AdvancedAnnual report

    「The Company has selected the Prime Market. At present, it fails to meet only the “listed shares market capitalisation” criterion among the Prime Market's continued listing criteria, so it prepared and announced in November 2021 a “Plan for Compliance with the Continued Listing Criteria for the New Market Segments”. Going forward, it will work to strengthen its competitiveness and profitability and pursue various initiatives, including trusted manufacturing, the promotion of the SDGs and shareholder return measures, with the aim of achieving the Prime Market's continued listing criteria at an early date.」

    The Company announced a plan in November 2021 for compliance with the Prime Market's continued listing criteria and specified measures for achieving them.
  4. FY2022-Q2First statedAnnual report

    「Regarding the Tokyo Stock Exchange's planned market-segment review in April 2022, the Company announced in October 2021 its policy of selecting the Prime Market. At present, it does not meet the “listed shares market capitalisation” criterion for continued listing on the Prime Market. Going forward, it aims to achieve the Prime Market's continued listing criteria ahead of schedule by increasing corporate value over the medium to long term through sustainable growth and improved profit levels, while further strengthening corporate governance.」

    Ahead of the market-segment review in April 2022, the Company announced its policy of selecting the Prime Market. It disclosed that it did not meet the listed shares market capitalisation criterion and is aiming for early achievement through sustainable growth, improved profit levels and stronger governance.
Moved together

"Development of High-Performance Contact Lenses and Medical and Pharmaceutical Products" moved the same way as this thread, in the same document, in 3 of its 10 moves.

322222★123456
  1. ★This thread
  2. 1Development of High-Performance Contact Lenses and Medical and Pharmaceutical Products3×
  3. 2Strengthening Production and Development Capabilities2×
  4. 3Launch of New Products and Expanded Specifications for Existing Products2×
  5. 4Expansion of production capacity and capabilities for new materials through the new building at the Konosu Research Institute2×
  6. 5Procurement Risk for Products, Materials and Raw Materials2×
  7. 6Growth through increasing domestic market share and developing overseas sales channels2×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Seed yet. It last moved in the Occurring Fact of 2026-10-14: "Advanced".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Prime Market Selection and Early Achievement of Listing Maintenance Criteria | SEED CO.,LTD. (7743) | Komori